Report i Specialty Pharmacy Data Value Management Learn More White Paper i Do Pharma Companies Need To Rethink Their Sales Operations Design? Learn More White Paper i Coronavirus Pandemic Effects On Incentive Compensation Learn More White Paper i Designing A Patient-Centric Commercial Strategy Learn More White Paper i Can The Coronavirus Contagion Economically Infect The Global Pharmaceutical Industry? Learn More White Paper i Importation Of Drugs Is Back Again On The Pharma Public Policy Table – A Short Commentary Learn More White Paper i Pharma’s Bold And Potentially Risky New Cancer Drug R&D Portfolio Strategy Learn More White Paper i How Will The Next Great Recession Affect The US Pharma Industry? Learn More White Paper i Do Pharma Mergers And Acquisitions Improve R&D Productivity And Increase Shareholder Value? Learn More Report i How Regulatory Changes Are Driving The Future Of The Medical Device Industry Learn More White Paper i Growing Attention Being Paid To Pharma Company Rebates And Discounts Learn More White Paper i Perspectives On Pharma Company Use Of Open Payments Data Learn More White Paper i Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US Learn More White Paper i Is The CVS-Aetna Merger A Pharma Industry Transformative Event? Learn More White Paper i How Will The 2018 Midterm Congressional Election Results Affect The US Pharma Industry? Learn More White Paper i Deploying K-Nearest Neighbor Modeling Methodologies For Real World Problems Learn More Article i Latest Pharma R&D Cost Estimates – Implications For The Expanded Use Of Commercial Analytics Learn More White Paper i The Changing Role Of Pharma Sales And Marketing In A Specialty Medicine Environment Learn More White Paper i The Relationship Between Drug Price Controls And Patient Health Outcomes Learn More White Paper i Patient Claims Versus EHR Data – How To Choose Between The Two? Learn More Blog i Is Biopharmaceutical Industry Drug Demand Becoming More Recession Sensitive? Learn More White Paper i Pharma Sales And Marketing Restrictions – Has the Pendulum Swung Too Far? Learn More White Paper i Econometric Analysis Of Biopharmaceutical Transfer Pricing Learn More White Paper i Make US Pharma Great Again!? – Part 1 Learn More White Paper i Make US Pharma Great Again!? – Part 2 Learn More Blog i Implications From HEOR And RWE Models For Biopharmaceutical Commercial Analytics Learn More White Paper i Global Pharma Pricing and Market Effects of President Trump’s Proposed Policies Learn More White Paper i Pricing and Market Effects of Biosimilar Entry in the US Learn More White Paper i The Reasons for and Solutions to Chronic Drug Shortages in the United States Learn More White Paper i The Value of Machine Learning and Data Mining in Pharmaceutical Commercial Analytics Learn More White Paper i The Causes and Solutions of Chronic Drug Shortages in the United States Learn More
